FOXG1 Improves Cognitive Function in Alzheimer's Disease by Promoting Endogenous Neurogenesis

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Alzheimer's disease (AD) is characterized by neurodegeneration and cognitive decline.
• Neural stem cell (NSC) dysfunction impairs the brain's ability to repair itself.
• The role of Forkhead-box gene 1 (FOXG1) in AD pathogenesis is largely unexplored.

Purpose of the Study:

• To investigate the association between Foxg1 gene variants and AD-related deficits.
• To explore FOXG1's role in regulating adult neurogenesis in AD.
• To determine if targeting the FOXG1-regulated cell cycle can promote neurogenesis in AD.

Main Methods:

• Overexpression of FOXG1 in the hippocampus of AD model brains using adeno-associated virus vectors.
• Assessment of behavioral deficits, amyloid-beta aggregation, and p21 expression.
• Evaluation of NSC activation, proliferation, and neuronal differentiation.

Main Results:

• FOXG1 overexpression rescued spatial learning, memory, and sensorimotor gating deficits in AD animals.
• FOXG1 inhibited p21-mediated cell cycle arrest, promoting NSC activation and proliferation.
• Increased neuroblast differentiation and generation of new neurons in the hippocampus of AD animals.

Conclusions:

• FOXG1 plays a critical role in promoting adult neurogenesis in AD by regulating NSC self-renewal and neuronal differentiation.
• The interplay between FOXG1 and p21 is crucial for endogenous neurogenesis in AD.
• Elevating FOXG1 levels presents a potential therapeutic avenue for AD treatment.